Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.

Lloyd-Smith P, Younger J, Lloyd-Smith E, Green H, Leung V, Romney MG.

J Hosp Infect. 2013 Sep;85(1):54-9. doi: 10.1016/j.jhin.2013.06.016. Epub 2013 Aug 6.

PMID:
23920443
2.

Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.

Jung E, Byun S, Lee H, Moon SY, Lee H.

Am J Infect Control. 2014 Oct;42(10):1062-6. doi: 10.1016/j.ajic.2014.06.024.

PMID:
25278394
3.

Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.

Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP.

Infect Control Hosp Epidemiol. 2001 Jul;22(7):437-42.

PMID:
11583213
4.

Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.

Butler AM, Olsen MA, Merz LR, Guth RM, Woeltje KF, Camins BC, Fraser VJ.

Infect Control Hosp Epidemiol. 2010 Jan;31(1):28-35. doi: 10.1086/649020.

5.
6.

Vancomycin-resistant enterococci colonization does not increase mortality in end-stage kidney failure: a case-control study.

Garner SE, Polkinghorne KR, Kotsanas D, Kerr PG, Korman TM, Stuart RL.

J Hosp Infect. 2013 Dec;85(4):289-96. doi: 10.1016/j.jhin.2013.09.005. Epub 2013 Sep 21.

PMID:
24161798
7.

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.

Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

Clin Microbiol Infect. 2013 Apr;19(4):E181-9. doi: 10.1111/1469-0691.12132. Epub 2013 Feb 7.

8.

Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.

Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW.

Intensive Care Med. 2002 Jun;28(6):692-7. Epub 2002 Apr 12.

PMID:
12107672
9.

Health and economic outcomes of vancomycin-resistant enterococci.

Carmeli Y, Eliopoulos G, Mozaffari E, Samore M.

Arch Intern Med. 2002 Oct 28;162(19):2223-8.

PMID:
12390066
10.

Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.

Mauldin PD, Salgado CD, Durkalski VL, Bosso JA.

Ann Pharmacother. 2008 Mar;42(3):317-26. doi: 10.1345/aph.1K501. Epub 2008 Feb 19.

PMID:
18285560
11.

The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.

Salgado CD.

Am J Infect Control. 2008 Dec;36(10):S175.e5-8. doi: 10.1016/j.ajic.2008.10.010.

PMID:
19084155
12.

[Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].

Yiş R, Aslan S, Cıtak C, Değirmenci S.

Mikrobiyol Bul. 2011 Oct;45(4):646-54. Turkish.

PMID:
22090295
13.
14.

Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.

Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM.

Infect Control Hosp Epidemiol. 2002 Aug;23(8):429-35.

PMID:
12186207
15.

Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan.

Lee SC, Wu MS, Shih HJ, Huang SH, Chiou MJ, See LC, Siu LK.

BMC Infect Dis. 2013 Apr 4;13:163. doi: 10.1186/1471-2334-13-163.

16.

Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.

Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, Ormiston D, Conly J; Canadian Nosocomial Infection Surveillance Program..

Infect Control Hosp Epidemiol. 2008 Mar;29(3):271-4. doi: 10.1086/528812.

PMID:
18241031
17.

Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.

Grabsch EA, Mahony AA, Cameron DR, Martin RD, Heland M, Davey P, Petty M, Xie S, Grayson ML.

J Hosp Infect. 2012 Dec;82(4):234-42. doi: 10.1016/j.jhin.2012.08.010. Epub 2012 Oct 25.

PMID:
23103245
18.

Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.

Gearhart M, Martin J, Rudich S, Thomas M, Wetzel D, Solomkin J, Hanaway MJ, Aranda-Michel J, Weber F, Trumball L, Bass M, Zavala E, Steve Woodle E, Buell JF.

Clin Transplant. 2005 Dec;19(6):711-6.

PMID:
16313314
19.

[Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba].

Reale AL, Depetri ML, Culasso C, Paviolo M, Cheguirián ML, Enrico MC, Ledesma EM, Vidal C, Glatstein E, Bertoni L.

Rev Argent Microbiol. 2009 Apr-Jun;41(2):92-6. Spanish.

20.

Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.

Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, Kim WJ.

Am J Infect Control. 2009 Nov;37(9):734-40. doi: 10.1016/j.ajic.2008.09.025. Epub 2009 Feb 1.

PMID:
19188004

Supplemental Content

Support Center